Tag: tamoxifenResistant

Articles

• ER+/PR- breast cancer characteristics
• Foods to eat and avoid during tamoxifen treatment
• Impact of endocrine therapy (hormone therapy) on BC prognosis

News

05/28/23

Exposure to cadmium reduces effectiveness of tamoxifen

05/03/22

EGFR inhibition reduces resistance to tamoxifen treatment

01/12/15

Early birth control pill use linked to premenopausal BC recurrence

08/24/14

Exposure to light at night reduces tamoxifen effectiveness

07/31/13

Resveratrol enhances the treatment effects of tamoxifen

05/07/13

Luteolin improves treatment in tamoxifen-resistant BC

04/19/12

Green tea polyphenol EGCG slows development of tamoxifen resistance

03/30/11

Although similar, ER+/PR- BC is more aggressive than ER+/PR+

05/19/10

Omega-6 rich corn oil reduces effectiveness of tamoxifen

03/17/10

EGCG has anti-cancer effects in tamoxifen-resistant cells

Studies

• Abstract PO4-24-09: Grape seed extract inhibits EGFR signaling pathway as a main factor of tamoxifen resistant in hormone receptor positive breast cancer Cite
  Jung SP, Lee E, You JY, Chun JH, Kim H. Abstract PO4-24-09: Grape seed extract inhibits EGFR signaling pathway as a main factor of tamoxifen resistant in hormone receptor positive breast cancer. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:PO4-24-09-PO4-24-09 10.1158/1538-7445.sabcs23-po4-24-09
• Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells Cite
  Mandal D, Sahu BR, Parija T. Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells. Medical Oncology. Springer Science and Business Media LLC; 2023; 40 10.1007/s12032-023-02081-y
• Pterostilbene–isothiocyanate reduces miR-21 level by impeding Dicer-mediated processing of pre-miR-21 in 5-fluorouracil and tamoxifen-resistant human breast cancer cell lines Cite
  Kumar V, Haldar S, Saini S, Ghosh S, Dhankhar P, Roy P. Pterostilbene–isothiocyanate reduces miR-21 level by impeding Dicer-mediated processing of pre-miR-21 in 5-fluorouracil and tamoxifen-resistant human breast cancer cell lines. 3 Biotech. Springer Science and Business Media LLC; 2023; 13 10.1007/s13205-023-03582-3
• Abstract 3902: Glutathione as a potential marker of tamoxifen resistance in breast cancer Cite
  Hamadneh YI, AlWahsh M, Alrawabdeh J, Hergenröder R, Dahabiyeh LA, Hamadneh L. Abstract 3902: Glutathione as a potential marker of tamoxifen resistance in breast cancer. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:3902-3902 10.1158/1538-7445.am2023-3902
• Environmental exposure to cadmium in breast cancer – association with the Warburg effect and sensitivity to tamoxifen Cite
  Tarhonska K, Janasik B, Roszak J, Kowalczyk K, Lesicka M, Reszka E, et al. Environmental exposure to cadmium in breast cancer – association with the Warburg effect and sensitivity to tamoxifen. Biomedicine & Pharmacotherapy. Elsevier BV; 2023; 161:114435 10.1016/j.biopha.2023.114435
• Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer Cite
  Naumann FV, Sweep FCGJ, Adema GJ, Peeters WJM, Martens JWM, Bussink J, et al. Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer. Cancer & Metabolism. Springer Science and Business Media LLC; 2023; 11 10.1186/s40170-023-00304-4
• EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells Cite
  Takeda T, Tsubaki M, Matsuda T, Kimura A, Jinushi M, Obana T, et al. EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells. Oncology Reports. Spandidos Publications; 2022; 47 10.3892/or.2022.8320
• Metformin reverses tamoxifen resistance through the lncRNA GAS5-medicated mTOR pathway in breast cancer Cite
  Jiang Y, Qian T, Li S, Xie Y, Tao M. Metformin reverses tamoxifen resistance through the lncRNA GAS5-medicated mTOR pathway in breast cancer. Annals of Translational Medicine. AME Publishing Company; 2022; 10:366-366 10.21037/atm-22-795
• Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α Cite
  Chen Y, Zhang J, Zhang M, Song Y, Zhang Y, Fan S, et al. Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α. Clinical and Translational Medicine. Wiley; 2021; 11 10.1002/ctm2.577
• Diethylhexyl Phthalate and Bisphenol A Promote Vincristine and Tamoxifen Resistance in Vitro Cite
  Uyar R, Yurdakok-Dikmen B, Turgut Y, Filazi A. Diethylhexyl Phthalate and Bisphenol A Promote Vincristine and Tamoxifen Resistance in Vitro. Chemical Research in Toxicology. American Chemical Society (ACS); 2022; 10.1021/acs.chemrestox.2c00002
• Cholesterol Depletion Modulates Drug Resistance Pathways to Sensitize Resistant Breast Cancer Cells to Tamoxifen Cite
  HENRIQUES PALMA GB, KAUR M. Cholesterol Depletion Modulates Drug Resistance Pathways to Sensitize Resistant Breast Cancer Cells to Tamoxifen. Anticancer Research. Anticancer Research USA Inc.; 2021; 42:565-579 10.21873/anticanres.15514
• Low concentrations of 17β‐estradiol exacerbate tamoxifen resistance in breast cancer treatment through membrane estrogen receptor‐mediated signaling pathways Cite
  Xu Z, Zhao D, Zheng X, Huang B, Pan X, Xia X. Low concentrations of 17β‐estradiol exacerbate tamoxifen resistance in breast cancer treatment through membrane estrogen receptor‐mediated signaling pathways. Environmental Toxicology. Wiley; 2021; 10.1002/tox.23417
• Role of estrogen receptor coregulators in endocrine resistant breast cancer Cite
  Altwegg KA, Vadlamudi RK. Role of estrogen receptor coregulators in endocrine resistant breast cancer. Exploration of Targeted Anti-tumor Therapy. Open Exploration Publishing; 2021;:385-400 10.37349/etat.2021.00052
• CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Drug Response: A Secondary Analyses of the KARISMA Trial Cite
  He W, Eriksson M, Eliasson E, Grassmann F, Bäcklund M, Gabrielson M, et al. CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Drug Response: A Secondary Analyses of the KARISMA Trial. Annals of Oncology. Elsevier BV; 2021; 10.1016/j.annonc.2021.07.005
• Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer Cite
  Watanabe T, Oba T, Tanimoto K, Shibata T, Kamijo S, Ito K. Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer. PLOS ONE. Public Library of Science (PLoS); 2021; 16:e0252822 10.1371/journal.pone.0252822
• Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer Cite
  Menendez JA, Papadimitropoulou A, Vander Steen T, Cuyàs E, Oza-Gajera BP, Verdura S, et al. Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer. Cancers. MDPI AG; 2021; 13:1132 10.3390/cancers13051132
• Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells Cite
  Hamadneh L, Abuarqoub R, Alhusban A, Bahader M. Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells. Scientific Reports. Springer Science and Business Media LLC; 2020; 10 10.1038/s41598-020-78833-x
• Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells Cite
  López-Sánchez LM, Mena R, Guil-Luna S, Mantrana A, Peñarando J, Toledano-Fonseca M, et al. Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells. Laboratory Investigation. Springer Science and Business Media LLC; 2020; 10.1038/s41374-020-00507-z
• The apple dihydrochalcone phloretin suppresses growth and improves chemosensitivity of breast cancer cells via inhibition of cytoprotective autophagy Cite
  Chen M, Gowd V, Wang M, Chen F, Cheng K. The apple dihydrochalcone phloretin suppresses growth and improves chemosensitivity of breast cancer cells via inhibition of cytoprotective autophagy. Food & Function. Royal Society of Chemistry (RSC); 2020; 10.1039/d0fo02362k
• MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway Cite
  Wu H, Liu Y, Hsu K, Wang Y, Chan Y, Chen Y, et al. MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway. The American Journal of Chinese Medicine. World Scientific Pub Co Pte Lt; 2020; 48:1221-1241 10.1142/s0192415x20500603
• Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin Cite
  Delort L, Bougaret L, Cholet J, Vermerie M, Billard H, Decombat C, et al. Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin. Nutrients. MDPI AG; 2019; 11:2839 10.3390/nu11122839
• 17β-estradiol at low concentrations attenuates the efficacy of tamoxifen in breast cancer therapy Cite
  Xu Z, Zheng X, Xia X, Wang X, Luo N, Huang B, et al. 17β-estradiol at low concentrations attenuates the efficacy of tamoxifen in breast cancer therapy. Environmental Pollution. Elsevier BV; 2019; 255:113228 10.1016/j.envpol.2019.113228
• LLGL2 rescues nutrient stress by promoting leucine uptake in ER+ breast cancer Cite
  Saito Y, Li L, Coyaud E, Luna A, Sander C, Raught B, et al. LLGL2 rescues nutrient stress by promoting leucine uptake in ER+ breast cancer. Nature. Springer Science and Business Media LLC; 2019; 569:275-279 10.1038/s41586-019-1126-2
• Abstract P2-05-06: Effects of a soy isoflavone in breast cancer treatment Cite
  Hatono M, Ikeda H, Taira N, Suzuki Y, Kajiwara Y, Kawata K, et al. Abstract P2-05-06: Effects of a soy isoflavone in breast cancer treatment. Poster Session Abstracts. American Association for Cancer Research; 2019; 10.1158/1538-7445.sabcs18-p2-05-06
• CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy Cite
  Mayer SE, Weiss NS, Chubak J, Doody DR, Carlson CS, Makar KW, et al. CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. Cancer Causes & Control. Springer Science and Business Media LLC; 2018; 30:103-112 10.1007/s10552-018-1117-x
• The modulatory role of low concentrations of bisphenol A on tamoxifen-induced proliferation and apoptosis in breast cancer cells Cite
  Huang B, Luo N, Wu X, Xu Z, Wang X, Pan X. The modulatory role of low concentrations of bisphenol A on tamoxifen-induced proliferation and apoptosis in breast cancer cells. Environmental Science and Pollution Research. Springer Science and Business Media LLC; 2018; 26:2353-2362 10.1007/s11356-018-3780-6
• Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen Cite
  Bougaret L, Delort L, Billard H, Le Huede C, Boby C, De la Foye A, et al. Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen. PLOS ONE. Public Library of Science (PLoS); 2018; 13:e0191571 10.1371/journal.pone.0191571
• ID:2024 Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticle and its Cytotoxicity Effects in Tamoxifen-resistant Breast Cancer Cells Cite
  Ahmad R, Kaus NHM, Hamid S. ID:2024 Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticle and its Cytotoxicity Effects in Tamoxifen-resistant Breast Cancer Cells. Biomedical Research and Therapy. Biomedical Research and Therapy; 2017; 4:55 10.15419/bmrat.v4is.248
• Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death Cite
  Leignadier J, Dalenc F, Poirot M, Silvente-Poirot S. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death. Biochemical Pharmacology. Elsevier BV; 2017; 144:18-28 10.1016/j.bcp.2017.06.120
• Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells Cite
  Cheng R, Liu Y, Cui J, Yang M, Liu X, Li P, et al. Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells. Oncotarget. Impact Journals, LLC; 2017; 8:30252-30264 10.18632/oncotarget.16325
• Naringenin Inhibits Proliferation and Survival of Tamoxifen‐ Resistant Breast Cancer Cells Cite
  Ramos J, Hatkevich T, Eanes L, Santos-Sanchez I, Patel YM. Naringenin Inhibits Proliferation and Survival of Tamoxifen‐ Resistant Breast Cancer Cells. Breast Cancer - From Biology to Medicine. InTech; 2017; 10.5772/66698
• Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model Cite
  Hilakivi-Clarke L, Wärri A, Bouker KB, Zhang X, Cook KL, Jin L, et al. Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model. Journal of the National Cancer Institute. Oxford University Press (OUP); 2016; 109:djw188 10.1093/jnci/djw188
• Abstract 215: Metabolic and mitochondrial consequences of p53 upregulation and their relation to cell fate outcomes Cite
  Christina Y, Frazier K, Rothschild D, Mookerjee S, Brand M, Scott G, et al. Abstract 215: Metabolic and mitochondrial consequences of p53 upregulation and their relation to cell fate outcomes. Molecular and Cellular Biology, Genetics. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-215
• Abstract C65: Defining the implications of sugar derived metabolites (AGEs) to tamoxifen resistance and breast cancer disparity: Is it a question of lifestyle? Cite
  Walter KR, Smith DM, Phan V, spruill L, Ford ME, Findlay VJ, et al. Abstract C65: Defining the implications of sugar derived metabolites (AGEs) to tamoxifen resistance and breast cancer disparity: Is it a question of lifestyle?. Organ Site Research. American Association for Cancer Research; 2016; 10.1158/1538-7755.disp15-c65
• The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling Cite
  Scherbakov AM, Sorokin DV, Tatarskiy VV, Prokhorov NS, Semina SE, Berstein LM, et al. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling. IUBMB Life. Wiley; 2016; 68:281-292 10.1002/iub.1481
• Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance Cite
  Bekele RT, Venkatraman G, Liu R, Tang X, Mi S, Benesch MGK, et al. Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep21164
• Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16 887 Breast Cancer Survivors Cite
  Haque R, Shi J, Schottinger JE, Ahmed SA, Cheetham TC, Chung J, et al. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16 887 Breast Cancer Survivors. Journal of the National Cancer Institute. Oxford University Press (OUP); 2015; 108:djv337 10.1093/jnci/djv337
• In vitro inhibitory effects of herbal supplements on tamoxifen and irinotecan metabolism Cite
  Grappe F, Nance G, Coward L, Gorman G. In vitro inhibitory effects of herbal supplements on tamoxifen and irinotecan metabolism. Drug Metabolism and Drug Interactions. Walter de Gruyter GmbH; 2014; 29 10.1515/dmdi-2014-0017
• Breast cancer recurrence in relation to antidepressant use Cite
  Chubak J, Bowles EJA, Yu O, Buist DSM, Fujii M, Boudreau DM. Breast cancer recurrence in relation to antidepressant use. Cancer Causes & Control. Springer Science and Business Media LLC; 2015; 27:125-136 10.1007/s10552-015-0689-y
• Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells Cite
  Kim HS, Tian L, Jung M, Choi SK, Sun Y, Kim H, et al. Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0141110 10.1371/journal.pone.0141110
• Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells Cite
  van Agthoven T, Dorssers LCJ, Lehmann U, Kreipe H, Looijenga LHJ, Christgen M. Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0136845 10.1371/journal.pone.0136845
• mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells Cite
  Karthik G, Ma R, Lövrot J, Kis LL, Lindh C, Blomquist L, et al. mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells. Cancer Letters. Elsevier BV; 2015; 367:76-87 10.1016/j.canlet.2015.07.017
• Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells Cite
  KIM S, LEE J, OH SJ, NAM SJ, LEE JE. Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells. Oncology Reports. Spandidos Publications; 2015; 34:1613-1619 10.3892/or.2015.4116
• Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to Tamoxifen Therapy in Breast Cancer Cite
  Dauchy RT, Xiang S, Mao L, Brimer S, Wren MA, Yuan L, et al. Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to Tamoxifen Therapy in Breast Cancer. Cancer Research. American Association for Cancer Research (AACR); 2014; 74:4099-4110 10.1158/0008-5472.can-13-3156
• 1α,25-Dihydroxyvitamin D3 inhibits cell growth and NFκB signaling in tamoxifen-resistant breast cancer cells Cite
  Lundqvist J, Yde CW, Lykkesfeldt AE. 1α,25-Dihydroxyvitamin D3 inhibits cell growth and NFκB signaling in tamoxifen-resistant breast cancer cells. Steroids. Elsevier BV; 2014; 85:30-35 10.1016/j.steroids.2014.04.001
• Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells Cite
  McCloy RA, Shelley EJ, Roberts CG, Boslem E, Biden TJ, Nicholson RI, et al. Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells. British Journal of Cancer. Springer Science and Business Media LLC; 2013; 109:3034-3041 10.1038/bjc.2013.693
• Resveratrol Sensitizes Tamoxifen in Antiestrogen-Resistant Breast Cancer Cells with Epithelial-Mesenchymal Transition Features Cite
  Shi X, Miao S, Wu Y, Zhang W, Zhang X, Ma H, et al. Resveratrol Sensitizes Tamoxifen in Antiestrogen-Resistant Breast Cancer Cells with Epithelial-Mesenchymal Transition Features. International Journal of Molecular Sciences. MDPI AG; 2013; 14:15655-15668 10.3390/ijms140815655
• Luteolin sensitises drug-resistant human breast cancer cells to tamoxifen via the inhibition of cyclin E2 expression Cite
  Tu S, Ho C, Liu M, Huang C, Chang H, Chang C, et al. Luteolin sensitises drug-resistant human breast cancer cells to tamoxifen via the inhibition of cyclin E2 expression. Food Chemistry. Elsevier BV; 2013; 141:1553-1561 10.1016/j.foodchem.2013.04.077
• Abstract 4874: Bisphenol A exposure negates tamoxifen-mediated chemoprevention in MMTV-erbB2 transgenic mice. Cite
  Yang X, Ma Z, Jiang Y. Abstract 4874: Bisphenol A exposure negates tamoxifen-mediated chemoprevention in MMTV-erbB2 transgenic mice.. Prevention Research. American Association for Cancer Research; 2013; 10.1158/1538-7445.am2013-4874
• Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer Cite
  Chen X, Zha X, Chen W, Zhu T, Qiu J, Røe OD, et al. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer. Biomedicine & Pharmacotherapy. Elsevier BV; 2013; 67:22-30 10.1016/j.biopha.2012.10.001
• Amurensin G inhibits angiogenesis and tumor growth of tamoxifen-resistant breast cancer via Pin1 inhibition Cite
  Kim J, Kim MR, Kim O, Phuong NTT, Yoon J, Oh WK, et al. Amurensin G inhibits angiogenesis and tumor growth of tamoxifen-resistant breast cancer via Pin1 inhibition. Food and Chemical Toxicology. Elsevier BV; 2012; 50:3625-3634 10.1016/j.fct.2012.07.027
• Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer Cite
  Stone A, Valdés-Mora F, Gee JMW, Farrow L, McClelland RA, Fiegl H, et al. Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer. PLoS ONE. Public Library of Science (PLoS); 2012; 7:e40466 10.1371/journal.pone.0040466
• Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer Cite
  Sandberg MEC, Hartman M, Klevebring D, Eloranta S, Ploner A, Hall P, et al. Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 134:793-800 10.1007/s10549-012-2096-3
• Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation Cite
  Yang X, Yang S, McKimmey C, Liu B, Edgerton SM, Bales W, et al. Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation. Carcinogenesis. Oxford University Press (OUP); 2010; 31:695-702 10.1093/carcin/bgq007
• Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells Cite
  Mai Z, Blackburn GL, Zhou J. Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells. Molecular Carcinogenesis. Wiley; 2007; 46:534-542 10.1002/mc.20300
• Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells Cite
  Banerjee S, Kambhampati S, Haque I, Banerjee SK. Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells. Journal of Cell Communication and Signaling. Springer Science and Business Media LLC; 2011; 5:317-324 10.1007/s12079-011-0138-y
• A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative Cite
  Thakkar JP, Mehta DG. A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative. The Oncologist. Wiley; 2011; 16:276-285 10.1634/theoncologist.2010-0302
• Omega-3 Fatty Acids for Prevention of Breast Cancer: an Update and the State of the Science Cite
  Iyengar NM, Hudis CA, Gucalp A. Omega-3 Fatty Acids for Prevention of Breast Cancer: an Update and the State of the Science. Current Breast Cancer Reports. Springer Science and Business Media LLC; 2013; 5:247-254 10.1007/s12609-013-0112-1
• (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line Cite
  Farabegoli F, Papi A, Bartolini G, Ostan R, Orlandi M. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine. Elsevier BV; 2010; 17:356-362 10.1016/j.phymed.2010.01.001
• Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study Cite
  Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austin PC, et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ. BMJ; 2010; 340:c693-c693 10.1136/bmj.c693
• Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells Cite
  Li Z, Carrier L, Rowan BG. Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells. Molecular Cancer Therapeutics. American Association for Cancer Research (AACR); 2008; 7:3056-3063 10.1158/1535-7163.mct-07-2142
• The Effect of the Phytoestrogens Genistein, Daidzein, and Equol on the Growth of Tamoxifen-Resistant T47D/PKCα Cite
  Tonetti DA, Zhang Y, Zhao H, Lim S, Constantinou AI. The Effect of the Phytoestrogens Genistein, Daidzein, and Equol on the Growth of Tamoxifen-Resistant T47D/PKCα. Nutrition and Cancer. Informa UK Limited; 2007; 58:222-229 10.1080/01635580701328545